Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Clinical and Experimental Immunology

• Publication date

  1991-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2249.1991.tb08117.xPMID 1849806PMCID PMC1535368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).

  1989cited by this paper
• Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2

  1989cited by this paper
• Isolation and antigenic profile of follicular dendritic cells.

  1989cited by this paper
• Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.

  1989cited by this paper
• Structure-function relationships of the complement components.

  1989cited by this paper
• Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia.

  1989cited by this paper
• Epstein-Barr virus/complement receptor and epithelial cells.

  1989cited by this paper
• A phenotypic study of cells from burkitt lymphoma and ebv‐b‐lymphoblastoid lines and their relationship to cells in normal lymphoid tissues

  1989cited by this paper
• Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.

  1988cited by this paper
• Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies

  1988cited by this paper
• B cells in patients with X-linked and 'common variable' hypogammaglobulinaemia.

  1986cited by this paper
• Autoantibodies against gp140, the Epstein‐Barr virus and C3d receptor in sera from rheumatoid arthritis patients

  1986cited by this paper
• Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.

  1985cited by this paper
• Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.

  1985cited by this paper
• Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients.

  1984cited by this paper
• Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody.

  1984cited by this paper
• The Follicular Dendritic Cell: Its Role in Antigen Presentation in the Generation of Immunological Memory

  1980cited by this paper
• Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins.

  1977cited by this paper
• structure–function relationships of the

  year unknowncited by this paper

• Soluble CD21: From Shedding to Autoimmunity

  2025influential citation
• B cell subpopulations in the pathogenesis of rheumatoid arthritis

  2019cites this paper
• Significance of Complement System in Ischemic Stroke: A Comprehensive Review

  2019cites this paper
• Analysis of post-transcriptional and architectural regulatory mechanisms controlling complement receptor gene expression in B cells

  2018cites this paper
• The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).

  2016cites this paper
• CD21−/low B cells: A Snapshot of a Unique B Cell Subset in Health and Disease

  2015cites this paper
• Detection of sCD21 in Human Blood Using ELISA is Influenced by Ethylenediaminetetraacetic Acid (EDTA) Containing Blood Collection Tubes.

  2015cites this paper
• Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression

  2012cites this paper
• B-cell activity in children with malaria

  2012cites this paper
• Serum levels of soluble CD21 in patients with systemic sclerosis

  2012cites this paper
• Ectodomain shedding and generation of two carboxy-terminal fragments of human complement receptor 2/CD21.

  2009cites this paper
• Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-β2-glycoprotein-I autoantibodies

  2008cites this paper
• Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease

  2008cites this paper
• Functional analysis of the cytoplasmic domain of complement receptor type II (CR2/CD21)

  2006cites this paper
• The role of CR2 in autoimmunity

  2006cites this paper
• Redox regulation of CD21 shedding involves signaling via PKC and indicates the formation of a juxtamembrane stalk

  2006cites this paper
• Receptors for complement C3 on T-lymphocytes: relics of evolution or functional molecules?

  2006cites this paper
• Reduction of Soluble Complement Receptor 2/CD21 in Systemic Lupus Erythomatosus and Sjögren's Syndrome but not Juvenile Arthritis

  2004cites this paper
• B cell activation leads to shedding of complement receptor type II (CR2/CD21)

  2003cites this paper
• Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation.

  2002influential citation
• Immunological Investigation of Human Complement Receptor Type II (CR2/CD21) : Serum Soluble CD21 in Health and Disease

  2002cites this paper
• Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes

  2000cites this paper
• Autocrine and paracrine growth mechanisms in human B lymphocytes

  1999cites this paper
• Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein.

  1998cites this paper
• Origin and properties of soluble CD21 (CR2) in human blood

  1998cites this paper
• Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.

  1998cites this paper
• The Clinical Laboratory: Testing the Complement System

  1998cites this paper
• Analysis of the human CD21 transcription unit reveals differential splicing of exon 11 in mature transcripts and excludes alternative splicing as the mechanism causing solubilization of CD21.

  1997cites this paper
• Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein‐Barr virus receptor, CR2) that binds iC3b and CD23

  1996cites this paper
• Expression of Epstein‐Barr virus nuclear antigen‐2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21

  1995cites this paper
• Synergy test for recognition of epitopes on soluble proteins; its application in the study of CD21 and CD23 antigens and their respective antibodies.

  1994cites this paper
• Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.

  1993cites this paper
• Determination of soluble CD21 as a parameter of B cell activation

  1993cites this paper
• Pitfalls in the measurement of soluble forms of cell surface receptors

  1993cites this paper
• Properties of soluble CR2 in human serum.

  1992cites this paper
• Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL)

  1991cites this paper